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Symptomatic Carotid Plaques Demonstrate Less Leaky Plaque
Microvasculature Compared With the Contralateral Side: A Dynamic
Contrast-Enhanced Magnetic Resonance Imaging Study
Genevieve A. J. C. Crombag, MD; Raf H. M. van Hoof, PhD; Robert J. Holtackers, MSc; Floris H. B. M. Schreuder, MD;
Martine T. B. Truijman, MD, PhD; Tobien A. H. C. M. L. Schreuder, MD; Narender P. van Orshoven, MD; Werner H. Mess, MD, PhD;
Paul A. M. Hofman, MD, PhD; Robert J. van Oostenbrugge, MD, PhD; Joachim E. Wildberger, MD, PhD; M. Eline Kooi, PhD
Background-—Rupture of a vulnerable carotid atherosclerotic plaque is an important underlying cause of ischemic stroke.
Increased leaky plaque microvasculature may contribute to plaque vulnerability. These immature microvessels may facilitate
entrance of inﬂammatory cells into the plaque. The objective of the present study is to investigate whether there is a difference in
plaque microvasculature (the volume transfer coefﬁcient Ktrans) between the ipsilateral symptomatic and contralateral
asymptomatic carotid plaque using noninvasive dynamic contrast-enhanced magnetic resonance imaging.
Methods and Results-—Eighty-eight patients with recent transient ischemic attack or ischemic stroke and ipsilateral >2 mm
carotid plaque underwent 3 T magnetic resonance imaging to identify plaque components and to determine characteristics of
plaque microvasculature. The volume transfer coefﬁcient Ktrans, indicative for microvascular density, ﬂow, and permeability, was
calculated for the ipsilateral and asymptomatic plaque, using a pharmacokinetic model (Patlak). Presence of a lipid-rich necrotic
core, intraplaque hemorrhage, and a thin and/or ruptured ﬁbrous cap was assessed on multisequence magnetic resonance
imaging. We found signiﬁcantly lower Ktrans in the symptomatic carotid plaque compared with the asymptomatic side
(0.0570.002 min1 versus 0.0620.002 min1; P=0.033). There was an increased number of slices with intraplaque
hemorrhage (0.91.6 versus 0.30.8, P=0.002) and lipid-rich necrotic core (1.41.9 versus 0.81.4, P=0.016) and a higher
prevalence of plaques with a thin and/or ruptured ﬁbrous cap (32% versus 17%, P=0.023) at the symptomatic side.
Conclusions-—Ktrans was signiﬁcantly lower in symptomatic carotid plaques, indicative for a decrease of plaque microvasculature in
symptomatic plaques. This could be related to a larger amount of necrotic tissue in symptomatic plaques.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov.uk. Unique identiﬁer: NCT01208025. ( J Am Heart Assoc. 2019;8:
e011832. DOI: 10.1161/JAHA.118.011832.)
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A therosclerosis of the carotid artery accounts for aboutone ﬁfth of ischemic strokes.1 Rupture of a vulnerable
atherosclerotic plaque can lead to thromboemboli and,
subsequently, to ischemic events.2–5 During the past decade,
it was demonstrated that patients with an increased stroke
risk can be identiﬁed on the basis of plaque composition on
magnetic resonance imaging (MRI) rather than degree of
stenosis.6,7 These studies focused on the presence of
intraplaque hemorrhage, a large lipid-rich necrotic core
(LRNC), and thinning or rupture of the ﬁbrous cap. In addition,
angiogenesis is thought to play a key role in atherogenesis,
but its exact role is still unclear. Plaque microvessels facilitate
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leakage of red blood cells and inﬂammatory cells into the
plaque tissue attributable to increased endothelial permeabil-
ity and can thereby contribute to plaque destabilization.8–12
Pharmacokinetic modeling of dynamic contrast-enhanced
magnetic resonance imaging (DCE MRI) can be used to
quantify plaque microvasculature noninvasively using phar-
macokinetic modeling.13–18 The pharmacokinetic parameter
Ktrans (volume transfer constant) is indicative for microvascu-
lar density, ﬂow, and permeability.19,20 A previous study
showed a strong positive correlation between vessel wall
Ktrans with the microvessel endothelium density on histology
(q=0.71; P<0.001) in 27 patients. We conﬁrmed in 23
patients with recent ischemic stroke and >50% carotid
stenosis, scheduled for carotid surgery, that Ktrans correlates
well with histologic quantiﬁcation of microvascular density
(q between 0.59 and 0.65; P<0.003).21,22
In vivo carotid plaque imaging gives the unique oppor-
tunity to study atherosclerotic plaques in patients noninva-
sively, which also enables one to study the plaque on the
contralateral, asymptomatic side, which is usually not
operated on and not often available for histologic studies.
Increased adventitial Ktrans in carotid plaques is associ-
ated with cardiovascular ischemic events.23 Although there
was no difference between adventitial Ktrans in symptomatic
versus asymptomatic plaques in patients with cardiovascu-
lar events, the number of patients may have been too small
to detect a signiﬁcant difference, as only 7 contralateral,
asymptomatic, carotid plaques were included in this
analysis.23
The main objective of our study is to investigate whether
there is a difference in microvasculature (Ktrans) between the
ipsilateral symptomatic and contralateral asymptomatic
carotid plaques in patients with a recent transient ischemic
attack or ischemic stroke.
Methods
For ethical reasons, the raw data that we collected cannot be
made publicly available. The study was approved by the
Medical Ethics Committee of the Maastricht University
Medical Center, Maastricht, The Netherlands, under the
condition that access to the data is granted only to (1)
members of the research team, (2) the Medical Ethics
Committee members who approved this study, and (3)
authorized personnel of the Health Care Inspectorate. Hence,
participants did not consent to publicly archiving their data.
However, requests for anonymized data can be sent to Prof Dr
Eline Kooi (eline.kooi@mumc.nl).
Study Population
Patients with a recent (<3 months) transient ischemic attack
and/or ischemic stroke in the anterior circulation and an
ipsilateral carotid artery plaque >2 mm but <70% stenosis
were prospectively included.24 Exclusion criteria were a
probable cardiac source of the embolism, a clotting disorder,
severe comorbidity, standard MRI contraindications, and a
renal clearance <30 mL/min. Institutional medical ethical
committee approval was obtained, and all patients provided
written informed consent. The degree of stenosis was
determined with multidetector-row computed tomography
based on the North American Symptomatic Carotid
Endarterectomy Trial criteria.24 Approval of the local Institu-
tional Ethical Review Board was obtained, and written
informed consent was obtained for all patients.
Magnetic Resonance Imaging
Patients underwent an MRI examination on a 3 T system
(Achieva; Philips Healthcare, Best, The Netherlands) using a
dedicated 8-channel carotid radio frequency coil (Shanghai
Chenguan Medical Technologies Co., Shanghai, China). A
multisequence MRI protocol, as described previously,24 was
used and consisted of the following sequences: pre- and
postcontrast T1 weighted (T1w) quadruple inversion recovery
(QIR) turbo spin echo (TSE), 3-dimensional time of ﬂight, T2
weighted (T2w) TSE, and 2-dimensional T1w inversion recov-
ery turbo ﬁeld echo.
In addition, for DCE MRI, an end-diastolic ECG-gated 3-
dimensional T1 fast ﬁeld echo MRI pulse sequence was
acquired. The central slice was placed at the position with the
highest plaque burden. The sequence consisted of the
following parameters: repetition/echo time 11.6/5.7 ms, ﬂip
angle 35°, ﬁeld of view 1309130 mm, acquisition/recon-
struction matrix 2089206/5129512, 5 adjoining transversal
slices, slice thickness 2 mm.20 The temporal resolution was
20 seconds per time frame, depending on the heart rate. A
Clinical Perspective
What Is New?
• This study demonstrates, using dynamic contrast-enhanced
magnetic resonance imaging, that there are fewer microves-
sels in the carotid symptomatic plaque compared with the
contralateral asymptomatic plaque in symptomatic patients
with carotid artery disease.
What Are the Clinical Implications?
• Carotid plaque microvasculature is often considered as a
vulnerable plaque characteristic; however, the present study
demonstrates that the relation between plaque microvas-
culature and clinical symptom development is more com-
plex.
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contrast medium, Gadobutrol (Gadovist, Bayer Healthcare,
Berlin, Germany) using a dose of 0.1 mmol/kg body weight,
was injected at the beginning of the third time frame. The
contrast medium was injected with a power injector (Spectris
Solaris, Medrad, Warrendale, PA) at a rate of 0.5 mL/s
followed by a 20-mL saline bolus at that same rate. The DCE
MRI acquisition was continued for 6 minutes after contrast
injection.
Magnetic Resonance Image Review
Magnetic resonance (MR) image review was performed by a
trained observer with dedicated vessel wall analysis software
(VesselMass, Leiden, The Netherlands)20 blinded to clinical data
and DCE MRI results. In case of doubt, a second highly
experienced observer was consulted. The inner and outer vessel
wall contours of the ipsilateral symptomatic carotid plaque and
the contralateral plaque on all slice positions were delineated.
Per slice, luminal and outer vessel wall contours were
drawn on the precontrast T1w QIR TSE, and in case of image
artifacts on postcontrast T1w QIR TSE, or T2 weighted TSE MR
images, in subsequent order. The DCE MR images were
coregistered with the multisequence MR images. Image
analysis was performed in the 5 slices that coregister with
the 5 DCE MRI slices and also on all 15 multisequence MRI
slices. The following aspects were assessed on the 5 MR
slices that coregister to DCE MR images: presence of plaque
(ie, maximum vessel wall thickness >1.5 mm), presence of a
LRNC, intraplaque hemorrhage, and a thin and/or ruptured
ﬁbrous cap. The presence of a LRNC was deﬁned as a region
within the bulk of the plaque that did not show contrast
enhancement on the postcontrast T1w QIR images. Presence
of intraplaque hemorrhage was scored on T1w inversion
recovery transient ﬁeld echo images by the trained observer.
Intraplaque hemorrhage was considered present in case of a
hyperintense signal in the bulk of the plaque, compared with
the sternocleidomastoid muscle and is considered as part of a
LRNC. On the postcontrast T1w TSE image, the ﬁbrous cap
was deﬁned as a high-signal area between the LRNC and the
lumen of the carotid artery.25 Fibrous cap status was
dichotomized according to a previously published categoriza-
tion.26 When a continuous high-signal area between intrapla-
que hemorrhage and the lumen was identiﬁed, ﬁbrous cap
status was classiﬁed as being “intact and thick.” When no or
an interrupted high-signal area was identiﬁed, ﬁbrous cap
status was classiﬁed as being “thin and/or ruptured.”
Luminal and outer vessel wall contours were transferred to
the DCE MR images, and if necessary, contours were manually
adjusted. The images acquired at each individual time frame
were inspected, and these images were shifted to correct for
small patient displacements during the dynamic acquisition, if
necessary. To avoid partial volume effects, luminal contours
were corrected by keeping sufﬁcient distance from the vessel
lumen. When the adventitial vasa vasorum showed hyperen-
hancement after contrast material administration, outer
plaque contours were corrected to include the adventitial
vasa vasorum. The entire vessel wall region is deﬁned as the
region between the luminal and outer wall contours. The
adventitial region of the vessel wall was deﬁned according to
previously described criteria,27 that is, all pixels within
0.625 mm of the outer wall contour in a region of the vessel
wall with plaque (ie, with a wall thickness >1.5 mm).
To evaluate potential differences in the positioning of the 5
DCE MRI slices with respect to the position with the largest
plaque burden at the symptomatic and asymptomatic side, we
identiﬁed the slice with the largest plaque burden at the
symptomatic and asymptomatic side on the 15 adjoining 2-
mm slices of the precontrast T1-weighted QIR TSE images. We
compared this slice position to the position of the middle slice
of the 5 DCE MRI slices.
Pharmacokinetic Modeling
Pharmacokinetic parameters were estimated using the Patlak
model28 on a voxel-wise basis, as previously described,29 with a
phase-based population-averaged vascular input function
determined in the carotid artery.20 Shortly, contrast medium
concentrations in the plaque were calculated from the signal
intensity time course by using the Ernst equation on the basis of
literature values for the longitudinal and transversal relaxation
times of tissue30 and the r1 and r2 relaxation rates of the
contrast medium,31 similar to previous studies.8,27,29,32
Statistical Analysis
All calculations were made with SPSS version 23 (IBM
Corporation, Armonk, NY). A P<0.05 was considered statis-
tically signiﬁcant. Data are presented as mean (plus or minus)
standard deviation for normally distributed data or number (n)
and percentage (%) for categorical data.
A paired-samples t test was used to investigate the
differences in mean Ktrans between the symptomatic and the
contralateral asymptomatic plaque in each patient and to
calculate differences in number of intraplaque hemorrhage
and LRNC-positive slices as well as differences in distance
between the slice with the largest plaque burden and the
middle DCE MRI slice between the symptomatic and asymp-
tomatic carotid artery. The difference in presence of
intraplaque hemorrhage, LRNC, and ﬁbrous cap status was
investigated using a McNemar test. Mean vessel wall Ktrans of
plaques with and without an LRNC were compared using an
independent-samples t test. Correlation between Ktrans and
time since last clinical event was evaluated using Spearman’s
correlation analysis for not normally distributed data.
DOI: 10.1161/JAHA.118.011832 Journal of the American Heart Association 3
Less Leaky Microvasculature in Symptomatic Plaques Crombag et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on October 13, 2019
Results
We performed MRI in 112 patients. Fourteen patients were
excluded because of low-quality ECG signal during scanning, 6
patients did not undergo an MRI examination (because of
obesity [n=2] and claustrophobia [n=4]), and 4 patients were
excluded because of insufﬁcient DCE MR image quality.
Eighty-eight patients, 70.18.4 years old and 63% males,
were available for analysis. Baseline clinical characteristics
are shown in Table 1.
Lower mean Ktrans of the entire vessel wall was found for
the ipsilateral symptomatic (0.0570.0020 min1) versus
the contralateral asymptomatic side (0.0620.0017 min1)
(P=0.033). Mean Ktrans of the adventitia did not differ between
the 2 sides (symptomatic 0.0580.0020 min1 versus
asymptomatic 0.0610.0028 min1; P=0.29); see Figure
and Table 2.
An overview of other plaque characteristics that are
identiﬁed on multisequence MRI slices that coregister to the
5 DCE MRI slices is provided for the symptomatic and
contralateral asymptomatic carotid artery in Table 2. The
results show a signiﬁcant difference in degree of stenosis
(53.11.6 versus 42.51.6; P<0.001) between the symp-
tomatic and asymptomatic sides, as well as a signiﬁcant
higher prevalence of intraplaque hemorrhage (28% versus
14%; P=0.015) and a thin and/or ruptured ﬁbrous cap (32%
versus 17%; P=0.023) on the symptomatic side in at least 1 of
the 5 multisequence MRI slices in the region covered by DCE
MRI. An LRNC was present in this region on the symptomatic
side in 41/88 (47%) patients and in 31/88 (35%) on the
asymptomatic side (P=0.132). Furthermore, there was a
tendency for a lower Ktrans of the entire vessel wall when a
LRNC was present versus no LRNC (0.0570.002 min1
versus 0.0610.003 min1, P=0.157). The mean difference
between the slice with the largest plaque burden and the
middle slice of the DCE MRI coverage was not signiﬁcantly
different on the symptomatic and asymptomatic side
(2.30.6 versus 3.10.7 slices; P=0.472).
On all 15 adjoining 2-mm multisequence MR images, there
was a signiﬁcantly higher prevalence of intraplaque hemor-
rhage (32% versus 15%; P=0.012), and LRNC (55% versus 44%;
P<0.001) on the symptomatic side; however, the prevalence
of a thin or ruptured cap was not signiﬁcantly different on the
symptomatic versus asymptomatic side (39% versus 40%;
P=1.0).
The median time interval between carotid MRI and last
clinical event was 4119 days. There was no signiﬁcant
correlation between Ktrans and the time since the last clinical
event (q=0.036, P=0.739).
Discussion
This study shows a signiﬁcantly lower Ktrans of the entire
plaque on the ipsilateral symptomatic side, compared with the
contralateral asymptomatic side in 88 symptomatic patients
with a recent transient ischemic stroke or ischemic stroke.
There was no signiﬁcant difference between symptomatic and
asymptomatic plaques for adventitial Ktrans. As expected,
more slices with LRNC and intraplaque hemorrhage and a
higher prevalence of a thin and/or ruptured ﬁbrous cap were
found in symptomatic plaques. Thus, the plaques at the
symptomatic side were more complicated, and these plaques
demonstrated fewer plaque microvessels.
Although our ﬁnding of less (leaky) plaque microvascula-
ture in the entire vessel wall on the symptomatic side may
Table 1. Patient Characteristics
Subjects, n (%) 88 (100)
Age, y 70.18.4
Male sex, n (%) 56 (63.6)
Body mass index, kg/m2 26.74.1
Currently smoking, n (%) 16 (21.1)
Diabetes mellitus, n (%) 14 (18.2)
Hypertension, n (%) 50 (56.8)
Hypercholesterolemia, n (%) 38 (43.7)*
Statin use before most recent cerebrovascular
event, n (%)
42 (47.7)*
Time between event and MRI, days 4119
Data are presented as meanSD or n (%). MRI indicates magnetic resonance imaging.
*One missing value.
Figure. Boxplot showing the signiﬁcant difference in vessel
wall Ktrans using a paired-samples t test between the symp-
tomatic (meanSEM; 0.0570.002 min1) and asymptomatic
(meanSEM; 0.0620.002 min1) side, with a P value of 0.03.
There was no signiﬁcant difference in adventitial Ktrans between
the symptomatic (meanSEM; 0.0580.002 min1) and
asymptomatic (meanSEM; 0.0610.0017 min1) side, with
a P value of 0.29.
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seem contraintuitive, as microvasculature is usually consid-
ered as a vulnerable plaque characteristic,33,34 an earlier
study also reported that Ktrans in the entire vessel wall was not
higher in symptomatic versus contralateral asymptomatic
plaques.23 In our study, the symptomatic plaques tended to
have a higher prevalence of LRNC. In addition, we found a
signiﬁcant larger number of slices with LRNC on the
symptomatic side. The LRNC consists of a large amount of
necrotic tissue, which may explain fewer leaky microvessels in
these plaques. The ﬁnding in the present study is also in line
with a previous contrast-enhanced ultrasound study that
detected plaque microvasculature in ﬁbrous and ﬁbro-fatty
tissue, while plaque microvasculature was not observed in
calciﬁed, necrotic, and hemorrhagic tissue.35 A large LRNC
increases the risk for plaque rupture and subsequent clinical
symptoms.36–39
In the adventitial region, no difference in Ktrans between
symptomatic and asymptomatic plaques was found, which is in
concordance with a previous study that also reported no
differences in adventitial Ktrans between asymptomatic (n=7)
and symptomatic carotid plaques (n=26) in patients with
cerebrovascular events.23 Previous studies have shown that the
LRNC ismostly present in the intimal layer andhardly in themedial
and adventitial layers, which may explain the lack of difference in
microvasculature for the adventitial microvasculature.3,40
In the 2 previous studies by Wang et al, different
parameters to study plaque microvasculature were used.
Their ﬁrst study used entire vessel wall Ktrans,41 while the later
study only reported adventitial Ktrans values.23 Therefore, we
reported both vessel wall Ktrans, as well as adventitial Ktrans
values in the present study, similar to our previous studies22
and in concordance with other DCE MRI studies.22,23,27,41
Deﬁning the adventitial region has been done using previously
described criteria,22,27 that is, all pixels within 0.625 mm of
the outer wall contour in a region of the vessel wall with
plaque (ie, with a wall thickness >1.5 mm). True differenti-
ation between adventitia and media/intima remains challeng-
ing with MRI techniques.
Wang et al41 demonstrated that Ktrans in carotid plaques is
associated with myocardial infarction and cerebrovascular
events. Therefore, there may be a systemic increase in plaque
microvasculature in patientswith cardiovascular ischemic events.
We did ﬁnd a signiﬁcantly lower degree of stenosis, a lower
prevalence of intraplaque hemorrhage, and a thin and/or
ruptured ﬁbrous cap on the contralateral carotid artery, which
indicates less advanced atherosclerotic plaques on the
asymptomatic side. Intuitively, one would expect a decrease
in leaky plaque microvasculature and thus a lower vessel wall
Ktrans in less advanced lesions. However, our study demon-
strated higher vessel wall Ktrans on the asymptomatic
compared with the symptomatic side. Therefore, it seems
unlikely that the higher vessel wall Ktrans is attributable to the
lower degree of stenosis or the lower prevalence of
intraplaque hemorrhage and a thin and/or ruptured ﬁbrous
cap on the asymptomatic side. This also indicates that the
relation between Ktrans and plaque vulnerability is complex, as
symptomatic plaques are known to have a higher risk of
future clinical events.
Table 2. Plaque Characteristics in the Symptomatic and Contralateral Asymptomatic Carotid Artery
n=88 Symptomatic Carotid Artery, n (%) Asymptomatic Carotid Artery, n (%) P Value
Degree of stenosis % (SEM) 53.1 (1.6)* 42.5 (1.6)*,† <0.001*
Presence of lipid-rich necrotic core 41 (47) 31 (35) 0.175
Number of slices with lipid-rich necrotic core per patient 1.4 (1.9) 0.8 (1.4) 0.016*
Presence of intraplaque hemorrhage 25 (28) 12 (14) 0.015*
Number of slices with intraplaque hemorrhage per patient 0.9 (1.6) 0.3 (0.8) 0.002*
Thin and/or ruptured fibrous cap 25 (28) 12 (14) 0.023*
Plaque >1.5 mm on 5 of 5 slices 61 (69) 59 (67) 0.291
Plaque >1.5 mm on 4 of 5 slices 15 (17) 13 (15)
Plaque >1.5 mm on 3 of 5 slices 7 (8) 5 (6)
Plaque >1.5 mm on 2 of 5 slices 3 (3) 8 (9)
Plaque >1.5 mm on 1 of 5 slice 1 (1) 3 (3)
Plaque >1.5 mm on 0 of 5 slices 1 (1) 0 (0)
Vessel wall K trans (SEM) 0.057 (0.002) 0.062 (0.002) 0.033
Adventitial K trans (SEM) 0.058 (0.002) 0.061 (0.003) 0.290
Assessed in the DCE MRI region (5 adjoining 2 mm slices).
*Data missing for 7 patients.
†Statistically signiﬁcant results.
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The rationale behind our study is to explore whetherKtrans can
contribute to a better risk stratiﬁcation of patients with carotid
atherosclerosis for surgical intervention. To be able to address
the risk differences of plaques, plaque features (such as
microvasculature) need to be reported on the whole plaque level
and not on different regions of plaques. Therefore, we used the
mean Ktrans values, similar to previous studies.8,21–23,27,42
A strength of our study is the relatively large sample size
compared with earlier DCE MRI studies of atherosclerotic
plaques.23,27,41 Our study has a number of limitations. First,
because of the cross-sectional design of this study, no
conclusion on causality can be drawn. Therefore, a possible
causal relationship between plaque microvasculature and
plaque symptomatology needs to be investigated in prospec-
tive studies. Second, the 2-dimensional DCE MRI sequence
that was used in our study has a limited coverage in the
longitudinal direction. During the MRI examination, the middle
DCE MRI slice was positioned at the level with the largest
plaque burden on the symptomatic side by visual inspection.
We veriﬁed that there was no signiﬁcant difference in distance
between the slice with the largest plaque burden on the
symptomatic and asymptomatic sides, respectively, and the
middle DCE MRI slice. Third, we used ﬁxed precontrast T1 and
T2 relaxation times to convert vessel wall signal intensity into
concentration. We chose this approach because a 3-
dimensional sequence with high spatial resolution T1 mapping
of the vessel wall was impractical in a clinical setting
attributable to time, temporal resolution, and signal-to-noise
constraints. A recent study described a multitasking approach
for high-spatial-resolution, high-temporal-resolution DCE MRI
including T1 mapping and large coverage of carotid arteries.
Conclusion
The symptomatic carotid plaque shows a signiﬁcantly lower
Ktrans for the entire vessel wall, indicative of a decrease of
plaque microvasculature in symptomatic plaques. This may be
related to a larger amount of necrotic tissue in symptomatic
plaques. There was no signiﬁcant difference in adventitial Ktrans
comparing the symptomatic with the asymptomatic side.
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